Nuclear Medicine Market - Global Trends and Forecast 2023

Transparency Market Research

Single User License: Nuclear Medicine Market Poised for Double-digit Growth!

Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.co m sales@transparencymarketresearch.com

USD 4315.5   

Flat 10% Discount!!



Report will be delivered with in 15-20 working days

Free Customization as per your requirement You will get Custom Report at Syndicated Report price

Request Sample

Buy Now

REPORT DESCRIPTION

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Nuclear Medicine Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Nuclear medicine refers to the application of radioactive isotopes for therapeutic and diagnostic purposes in medicine. The constituents of nuclear medicine include radioactive isotopes and radiological imaging devices such as magnetic resonance imaging (MRI), positron emission tomography (PET), computerized tomography (CT), and single proton emission tomography (SPECT). The basic principle of nuclear medicine is the use of radiological imaging devices to view the concentration of radioactive isotopes injected within the body thereby enabling a picture (2D) or real-time study (3D) of the patients anatomy. In some therapeutic applications, radioactive isotopes are selected in a way that they get excited when under the influence of radio waves from radiology equipment thereby treating a condition (mostly tumor) wherein the isotope is concentrated. Nuclear medicine has therefore seen a rise in their applicability over the past decades and is expected to continue with greater interests in treating life threatening diseases such as cancer..

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4672

Based on their application, nuclear medicines can be segregated majorly into: diagnostics and therapeutics. Diagnostic nuclear medicine can be further segmented into: cardiovascular, neurology, nephrology, hepatology, oncology, and pulmonology. The therapeutic applications of nuclear medicine majorly focus on cancer treatment and scar- tissue removal.

Geographically, the nuclear medicine market is segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World.

North America accounts for the largest share in terms of revenue due to several technological advancements and high cost associated with the nuclear medicines applications. Diagnostic nuclear medicine forms the largest application of nuclear medicine technology, radiopharmaceutical products and computer aided detection services in the region.

Therapeutic nuclear medicine follows diagnostic nuclear medicine in terms of applications. However therapeutic nuclear medicine being an expensive procedure has the potential to surpass diagnostic nuclear medicine in the future in terms of revenue. On the other hand European companies continue to remain a strong point in the global nuclear medicine market mainly due to the high quality of services offered, greater innovations and their increased reliability. Certain significant restrictions for nuclear medicine services such as shortage of radioactive isotopes, dearth of technical experts in hospitals and high cost of materials, continue to dampen the market growth especially in the cost sensitive economies of Asia Pacific region.

The demand for nuclear medicine services in the Asia Pacific region is expected to grow in the future due to increasing incidences of cancer, cardiovascular and neurological diseases, Australia, Japan, and China form the largest market in the Asia Pacific region as amajority of nuclear medicine diagnostic equipment manufacturing are from these countries. In addition Australia is among the world’s largest manufacturers of pharmaceutical radio-isotopes. South Asia and South East Asia on the other hand show great potential in terms of cardiovascular and neurological application. Therapeutic application of nuclear medicine for treating oncology cases are yet to be fully developed throughout the region, although countries such as Singapore exhibit a successful rate of nuclear medicine therapeutics.

Some of the key players contributing to the global nuclear medicine market include: G.E Healthcare, AIPES, COMECER S.P.A, Pinestar Technology, Inc., Ashby Gorman Baker Ltd, and Mediso Ltd.

About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/